Actos

Langdon & Emison represents clients nationwide who have been diagnosed with bladder cancer or have experienced cardiovascular side effects, such as heart attack, from taking the diabetes drug Actos. For a free case evaluation or to learn more about this ongoing litigation, contact our firm at 800-397-4910 or complete an online form.

Video: Dangerous Side Effects of Actos

What is Actos?

Actos (generic name pioglitazone) is a prescription medication commonly used to treat Type-2 diabetes for patients whose condition in not adequately controlled by diet and exercise alone. Actos belongs to a class of drugs called Thiazolidinedione drugs, which help to treat Type-2 diabetes by lowering blood glucose levels and increasing the body’s sensitivity to insulin.

Actos is manufactured by Takeda Pharmaceutical Company and is co-marketed in the United States by Eli Lilly Pharmaceuticals. The U.S. Food and Drug Administration (FDA) first approved Actos in 1999.

What is wrong with Actos?

The FDA has received more than 70 reports of bladder cancer from patients who took Actos, but these reports are voluntary and likely do not represent the true number of bladder cancer incidents associated with Actos. In addition, studies show that Actos users have almost double the risk of bladder cancer. Possible signs or symptoms of bladder cancer include:

  • Abdominal pain.
  • Blood in urine.
  • Painful and/or frequent urination.
  • Fatigue.
  • Weight loss.

In June 2011, the FDA issued an Actos drug safety alert, warning that the use of Actos for more than one year might be linked to an increased risk of bladder cancer. At the same time, health authorities in France suspended use of Actos due to the risk of developing bladder cancer.

Why are Actos lawsuits being filed nationwide?

Prescription drug manufacturers have a duty to patients to make safe products and to warn patients and their doctors of any adverse health effects. Takeda knew as early as 2004 that studies found links between Actos and bladder cancer, but the company did not issue a warning to patients and doctors until 2011.

What are the details of the Actos settlement?

In April 2015, Takeda Pharmaceuticals agreed to a $2.4 billion settlement to resolve more than 9,000 lawsuits from people claiming they were injured from taking Actos. To participate in the settlement, users had to meet these three criteria:

  1. They took Actos at some time prior to December 1, 2011.
  2. They were diagnosed with bladder cancer on or before April 28, 2015.
  3. They are represented by counsel, or retained counsel by May 1, 2015.

The deadline to participate in the settlement was September 11, 2015. Eligible recipients will receive payments of about $250,000 per person; payments will be increased for more severe injuries.

Can I still file an Actos lawsuit?

Yes. Even if you do not meet the three criteria listed above, you may still be eligible to file a lawsuit against Takeda and seek compensation for your injuries. Langdon & Emison will be pleased to review your case for free and without any obligation.

 

 

Contact Langdon & Emison

For more than 30 years, Langdon & Emison has successfully represented people who have been injured or lost loved ones due to the negligence of others. If you or someone you know developed bladder cancer or suffered injuries while taking Actos, contact our firm at 800-397-4910 or click on the button below.